Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000-until recently.

Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

Tony, an energetic 7-year-old who loves playing football and roughhousing with his brothers wasn’t all that excited when his ...

Some 400,000 Mainers rely on Medicaid for health care, and when looking at the number of people covered by Medicaid ...

Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased ...

A new study by the Institute of Cancer Research suggests this routine scan is responsible for as many cancer cases as alcohol ...

Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national ...

A retrospective study finds Medicare Advantage patients receive less advanced radiotherapy, with increased treatment duration ...

If we screened 70% of eligible adults for colon cancer, Medicare could save $14 billion by 2050. Imagine the lives and dollars we could save by prioritizing screening and preventive care for ...

Cancer diagnostics company Pacific Edge has failed in its attempted legal challenge of a US decision halting public funding ...

Cancer care can vary significantly from hospital to hospital, especially for patients considering clinical trials.  The quest ...